A PHP Error was encountered

Severity: Warning

Message: Undefined array key 1

Filename: helpers/my_audit_helper.php

Line Number: 6966

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 6966
Function: _error_handler

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3884
Function: getTopKeywords

File: /var/www/html/application/controllers/Detail.php
Line: 38
Function: pubMedSearch_Global

File: /var/www/html/index.php
Line: 316
Function: require_once

[Reirradiation]. | LitMetric

[Reirradiation].

Nihon Hoshasen Gijutsu Gakkai Zasshi

Miyakojima IGRT Clinic.

Published: January 2018

Download full-text PDF

Source
http://dx.doi.org/10.6009/jjrt.2017_JSRT_73.10.1069DOI Listing

Publication Analysis

Top Keywords

[reirradiation]
4
[reirradiation]
1

Similar Publications

In this paper, we review the use of hypofractionated radiotherapy for gastrointestinal malignancies, focusing on primary and metastatic liver cancer, and recurrent rectal cancer. Technological advancements in radiotherapy have facilitated the direct delivery of high-dose radiation to tumors, while limiting normal tissue exposure, supporting the use of hypofractionation. Hypofractionated radiotherapy is particularly effective for primary and metastatic liver cancer where high-dose irradiation is crucial to achieve effective local control.

View Article and Find Full Text PDF

Introduction: Locoregional recurrence (LR) is common in locally advanced head and neck cancer (HNSCC), posing challenges for treatment. We analysed outcome parameters and toxicities for patients being treated with radiotherapy (RT) for LR-HNSCC and investigated patient and disease related prognostic factors in this prognostically unfavourable group.

Methods: This analysis includes 101 LR-HNSCC patients treated with RT, radio-chemotherapy (RCT) or radio-immunotherapy (RIT) between 2010 and 2018 at a high-volume tertiary centre.

View Article and Find Full Text PDF

Objective: This review aims to formulate the most current, evidence-based recommendations regarding radiation therapy, radiosurgery, and chemotherapy for patients with metastatic spine tumors.

Methods: A systematic literature using PRISMA methodology was performed from 2010-2023 using the search terms "radiosurgery," "radiation therapy," "external beam radiation therapy," or "stereotactic body radiation therapy" in conjunction with "spinal," "spine," "metastasis," "metastases," or "metastatic."

Results: Spinal metastases should be managed in a multidisciplinary team consisting of spine surgeons, radiation oncologists, radiologists and oncologists.

View Article and Find Full Text PDF

Evolution of breast cancer management after mediastinal hodgkin lymphoma: Towards a breast- conserving approach.

Eur J Surg Oncol

December 2024

Department of Radiation Oncology, Institut Curie, Paris, France. Electronic address:

Purpose: To analyse the clinical and histological characteristics of breast cancers (BC) occurring after Hodgkin lymphoma (HL), as well as their outcome with particular attention to the effectiveness and safety of breast-conservative surgery with radiation therapy (RT).

Materials And Methods: This is a retrospective study of 218 patients who developed stage 0 to III BC after treatment for mediastinal HL between 1951 and 2022. Comprehensive demographic, clinical, and therapeutic data were collected for HL and BC, as well as survival and locoregional control.

View Article and Find Full Text PDF

Real life data of ONC201 (dordaviprone) in pediatric and adult H3K27-altered recurrent diffuse midline glioma: Results of an international academia-driven compassionate use program.

Eur J Cancer

December 2024

Department of Pediatric and Adolescent Oncology, Gustave Roussy, Villejuif, France; Team Genomics and Oncogenesis of Brain Tumors, INSERM U981, Paris Saclay University, Villejuif, France.

Introduction: H3K27-altered diffuse midline gliomas (DMG) have limited therapeutic options and a very poor prognosis. Encouraging responses were observed in early clinical trials with ONC201. As ONC201 was unavailable in Europe, a compassionate use program supported by the French Authorities was launched for patients at progression after standard of care radiotherapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!